Co-Authors
This is a "connection" page, showing publications co-authored by Naim Ata and Aysegul Atmaca.
Connection Strength
0.596
-
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporos Int. 2022 Jan; 33(1):273-282.
Score: 0.241
-
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. Diabetes Ther. 2021 Nov; 12(11):2857-2870.
Score: 0.060
-
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity). Exp Clin Endocrinol Diabetes. 2022 Feb; 130(2):115-124.
Score: 0.060
-
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia). Endocrine. 2021 08; 73(2):261-269.
Score: 0.060
-
The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study. Clin Endocrinol (Oxf). 2021 10; 95(4):628-637.
Score: 0.059
-
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes. 2021 Jul; 13(7):585-595.
Score: 0.059
-
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul. Diabetes Res Clin Pract. 2021 Apr; 174:108753.
Score: 0.058